Expression of Toll-Like Receptors in the Early Prenatal Development of the Human Retina


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The expression of Toll-like receptors TLR2 and TLR4 in the human retina during early prenatal development is shown for the first time. It was found that the development and differentiation of the retina is accompanied by specific spatial changes in the location of these receptors. TLR2 and TLR4 expression was detected in both neuroblastic retinal layers in gestation week 9. At subsequent developmental stages, the immunohistochemical staining for TLR2 and TLR4 gradually shifted towards the inner and outer plexiform layers of the retina and the nerve fiber layer. Our results suggest a possible involvement of these receptors in the regulation of neurogenesis and axonogenesis and the formation of synaptic connections between neurons and axons. The presence of TLR receptors in the endothelial cells forming retinal vessel walls does not exclude their role in the blood–retina barrier in pathogen infection.

作者简介

I. Panova

Koltzov Institute of Developmental Biology, Russian Academy of Sciences

编辑信件的主要联系方式.
Email: pinag@mail.ru
俄罗斯联邦, Moscow, 119334

N. Nizyaeva

Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology,
Ministry of Health of the Russian Federation

Email: pinag@mail.ru
俄罗斯联邦, Moscow, 117997

V. Sinitsyna

Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology,
Ministry of Health of the Russian Federation

Email: pinag@mail.ru
俄罗斯联邦, Moscow, 117997

R. Poltavtseva

Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology,
Ministry of Health of the Russian Federation

Email: pinag@mail.ru
俄罗斯联邦, Moscow, 117997

G. Sukhikh

Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology,
Ministry of Health of the Russian Federation

Email: pinag@mail.ru
俄罗斯联邦, Moscow, 117997

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2018